Akebia Therapeutics | AKBA - Passifs Courants





Passifs Courants Changement Date
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Akebia Therapeutics USD 162.35M 1.48M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Ardelyx USD 127.8M 4.42M 2026-09
Astellas Pharma JPY 1.1T 134.96B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Celltrion KRW 288.01B 4.7B 2026-06
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 28.51M 5.87M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Ironwood Pharmaceuticals USD 34.73M 1.88M 2026-09
J&J USD 55.46B 562M 2026-09
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.03B 506M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pharma Mar EUR 125.39M 26.97M 2026-09
Prothena USD 11.43M 224K 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09